13th Biopharma India 2015

Over 20% growth rate expected for India Pharma Industry in 2016

Emily Event News Leave a Comment

Despite government price control, IP, and quality issues, India remains the 3rd largest biotechnology economy in the APAC region. It was reported that the pharmaceutical industry in India will create 134,000 new jobs in 2016, equivalent to 20% more hiring as compared to 2015 (Source: India Skills Report 2016). Experts also suggested that India’s pharma industry will likely be listed as one of …

NIHR CRN's white paper

UK’s clinical research network achieves 65 first global patients in 3 years

Lydia Sebastian Event News Leave a Comment

Performance figures show that the UK is open for business The National Institute for Health Research (NIHR) Clinical Research Network has reached a milestone in study set-up achievements by recruiting 65 first global patients in commercial studies in the last three years. With many clinical research studies recruiting patients simultaneously from all over the world, a “global first patient” is …

matrix

Managing issues in eClinical operation and design

Emily Event News Leave a Comment

With the potential for speeding up results and improving success rates, pharma companies are excited to roll out eClinical methods in their clinical trials in the hope of fast tracking the long, tiring, trial process for ensuring the safety of drugs for human consumption. But how do pharma personnel make sure that it really helps in creating successful trial result? Does …

biopharma industry awards-dinner

Who made the greatest vaccines breakthrough in Asia?

Emily Event News Leave a Comment

Prevention is better than cure, that is the basis of all public health care policy across the world. As the most populated continent in the world, Asia is the home to more than 4.2 billion people, where more than 1.6 billion of them living in tropical climate. Naturally, diseases which grow in this comfortable, warm and humid climate are highly …

lab

Bringing antibodies from early development to clinic and beyond

Emily Event News Leave a Comment

Monoclonal antibodies (MAbs) are inherently sensitive to handle. In an effort to improve the specificity of oncology treatment, many pharma and biotech worked on combining these MAbs with cytotoxins to kill cancer cells. While it is challenging to synthesis these Antibody-drug conjugate (ADC) in lab, it is even harder to mass produce these macromolecules to run it through clinical trials …

Join us at BioPharma Asia Convention 2016
Clinical trials| Manufacturing| Supply Chain| Partnering| Vaccines| Biosimilars| Antibodies| Orphan drugs

3 key manufacturing takeaways you can expect from BioPharma Asia

Emily Event News Leave a Comment

With Asia’s biopharma boom set to continue with impressive year-on-year growth, you can’t afford to ignore this lucrative market. BioPharma Asia Convention 2016 returns to Singapore, bringing you more content than ever before, offering you a truly one-stop shop for taking advantage of the region’s potential. We’re bringing you more speakers and sessions than ever before, discussing the latest trends and …

pills

Rare Disease patient advocates & Orphan drug developers joining BioPharma Asia 2016

Emily Event News Leave a Comment

The World Orphan Drug Congress Asia is now a part of the 9th Biopharma Asia Convention. Pharma, government representatives and rare disorder patient advocates will now be gathered under the same roof to discuss on strategies to cater to the needs of minorities by building a more transparent orphan drug policies in Asia. Asia Pacific Alliance of Rare Disorders Organisations (APARDO), …

Join us at BioPharma Asia Convention 2016 
Clinical trials| Manufacturing| Supply Chain| Partnering| Vaccines| Infectious diseases| Biosimilars| Antibodies| Orphan drugs

Meet supply chain and trade regulation experts at BioPharma Asia Convention 2016

Emily Event News Leave a Comment

The lack of coherent supply chain regulation and trade practices remains the major challenge for pharma supply chain personnel in Asia. To make sure that your approved biologics drugs can be distributed to your local destination, you need to meet the right regulators and experts to optimise your supply chain practices. That’s why you should join us at BioPharma Asia. …

Photo with Dr Ajith Kamath(from left), Dr Renu Swarup, Dr Kaushik Deb, Mr Narasimha Rao, and Dr BN Manohar
Taken at BioPharma India Convention 2015, 3-4 November, Mumbai, India

Quick recap of 13th BioPharma India Convention, Mumbai

Emily Event News Leave a Comment

Photo with Dr Ajith Kamath(from left), Dr Renu Swarup, Dr Kaushik Deb, Mr Narasimha Rao, and Dr BN Manohar Taken at BioPharma India Convention 2015, 3-4 November, Mumbai, India According to IMS Health Asia Pacific, the following 10 companies were ranked to capture near 50% of the entire India pharma market share: Sun Pharma Abbott Cipla Mankind Zydus Cadila GSK Alkem …

Clinial trials| Manufacturing| Supply Chain| Partnering| Orphan drugs| Biosimilars| Antibodies| Vaccines | Infectious diseases

Top 5 reasons why you should join us at BioPharma Asia Convention

Emily Event News Leave a Comment

As you know, clinical development is a critical but lengthy part of the drug development process, as it determines the efficacy of a drug candidate in treating disease. When it takes an average of 10-15 years to push a drug candidate from lab discovery to regulatory approval, it is absolutely critical for clinical personnel to understand the best way to …